Cerebral Venous Thrombosis Associated with COVID-19

References

1. 1.↵
   1. Chen N,
   2. Zhou M,
   3. Dong X, et al

   . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13 doi:10.1016/S0140-6736(20)30211-7 pmid:32007143

   CrossRefPubMed
2. 2.↵
   1. Li Y,
   2. Wang M,
   3. Zhou Y, et al

   . Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. SSRN Electronic Journal January 2020. https://www.researchgate.net/publication/340154622_Acute_Cerebrovascular_Disease_Following_COVID-19_A_Single_Center_Retrospective_Observational_Study. Accessed April 13, 2020
3. 3.↵
   1. Wang W,
   2. Sun Q,
   3. Bao Y, et al

   . Analysis of risk factors for the thromboembolic events from 88 patients with COVID-19 pneumonia in Wuhan, China: a retrospective report. Lancet 2020 April 6. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3559633. Accessed April 13, 2020
4. 4.↵
   1. Xie Y,
   2. Wang X

   . COVID-19 complicated by acute pulmonary embolism. Images in Cardiothoracic Imaging March 16, 2020. https://pubs.rsna.org/doi/10.1148/ryct.2020200067. Accessed April 11, 2020
5. 5.↵
   1. Tang N,
   2. Li D,
   3. Wang X, et al

   . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844–47 doi:10.1111/jth.14768 pmid:32073213

   CrossRefPubMed
6. 6.↵
   1. Han H,
   2. Yang L,
   3. Liu R, et al

   . Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020 March 16. [Epub ahead of Print] doi:10.1515/cclm-2020-0188 pmid:32172226

   CrossRefPubMed
7. 7.↵
   1. Zhang Y,
   2. Xiao M,
   3. Zhang S, et al

   . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;382:e38 doi:10.1056/NEJMc2007575 pmid:32268022

   CrossRefPubMed
8. 8.↵
   1. Bibas M,
   2. Biava G,
   3. Antinori A

   . HIV-associated venous thromboembolism. Mediterr J Hematol Infect Dis 2011;3:e2011030 doi:10.4084/MJHID.2011.030 pmid:21869916

   CrossRefPubMed
9. 9.↵
   1. Squizzato A,
   2. Gerdes VE,
   3. Buller HR

   . Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost 2005;93:403–10 doi:10.1160/TH04-08-0523 pmid:15735787

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Uthman IW,
    2. Gharavi AE

    . Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002;31:256–63 doi:10.1053/sarh.2002.28303 pmid:11836658

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Gupta N,
    2. Zhao YY,
    3. Evans CE

    . The stimulation of thrombosis by hypoxia. Thromb Res 2019;181:77–83 doi:10.1016/j.thromres.2019.07.013 pmid:31376606

    CrossRefPubMed
12. 12.↵
    1. Ortel TL

    . Acquired thrombotic risk factors in the critical care setting. Crit Care Med 2010;38:S43–50 doi:10.1097/CCM.0b013e3181c9ccc8 pmid:20083913

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Canhao P,
    2. Ferro JM,
    3. Lindgren AG, et al

    ; ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005;36:1720–25 doi:10.1161/01.STR.0000173152.84438.1c pmid:16002765

    Abstract/FREE Full Text
14. 14.↵
    1. Girot M,
    2. Ferro JM,
    3. Canhao P, et al

    ; ISCVT Investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007;38:337–42 doi:10.1161/01.STR.0000254579.16319.35 pmid:17204682

    Abstract/FREE Full Text
15. 15.↵
    1. Gagnier JJ,
    2. Kienle G,
    3. Altman DG, et al

    ; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med 2013;2:38–43 doi:10.7453/gahmj.2013.008 pmid:24416692

    CrossRefPubMed
16. 16.↵
    1. Arrigoni F,
    2. Parazzini C,
    3. Righini A, et al

    . Deep medullary vein involvement in neonates with brain damage: an MR imaging study. AJNR Am J Neuroradiol 2011;32:2030–36 doi:10.3174/ajnr.A2687 pmid:21960491

    Abstract/FREE Full Text
17. 17.↵
    1. Ellchuk TN,
    2. Shah LM,
    3. Hewlett RH, et al

    . Suspicious neuroimaging pattern of thrombotic microangiopathy. AJNR Am J Neuroradiol 2011;32:734–38 doi:10.3174/ajnr.A2351 pmid:21292795

    Abstract/FREE Full Text
18. 18.↵
    1. Giannis D,
    2. Ziogas IA,
    3. Gianni P

    . Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 2020;127:104362 doi:10.1016/j.jcv.2020.104362 pmid:32305883

    CrossRefPubMed
19. 19.↵
    1. Saposnik G,
    2. Barinagarrementeria F,
    3. Brown RD Jr., et al

    ; American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:1158–92 doi:10.1161/STR.0b013e31820a8364 pmid:21293023

    Abstract/FREE Full Text
20. 20.↵
    1. Devasagayam S,
    2. Wyatt B,
    3. Leyden J, et al

    . Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke 2016;47:2180–82 doi:10.1161/STROKEAHA.116.013617 pmid:27435401

    Abstract/FREE Full Text
21. 21.↵
    1. Ribes M

    . Des recherches faites sur la phlébite. In: Académie Royale de Médecine. Revue Médicale Française et Etrangère et Journal de Clinique de l’Hôtel-Dieu et de la Charité de Paris 1825. 2018;3:5–41
22. 22.↵
    1. Zuurbier SM,
    2. Coutinho JM,
    3. Stam J, et al

    ; ISCVT Investigators. Clinical outcome of anticoagulant treatment in head or neck infection-associated cerebral venous thrombosis. Stroke 2016;47:1271–77 doi:10.1161/STROKEAHA.115.011875 pmid:27032446

    Abstract/FREE Full Text
23. 23.↵
    1. Krayenbuhl HA

    . Cerebral venous and sinus thrombosis. Neurol Med Chir (Tokyo) 1968;10:1–24 doi:10.2176/nmc.10.1 pmid:4194573

    CrossRefPubMed
24. 24.↵
    1. Ferro JM,
    2. Canhao P,
    3. Stam J, et al

    ; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664–70 doi:10.1161/01.STR.0000117571.76197.26 pmid:14976332

    Abstract/FREE Full Text
25. 25.↵
    1. Pabinger I,
    2. Grafenhofer H

    . Thrombosis during pregnancy: risk factors, diagnosis and treatment. Pathophysiol Haemost Thromb 2002;32:322–24 doi:10.1159/000073590 pmid:13679666

    CrossRefPubMedWeb of Science
26. 26.↵
    1. James AH,
    2. Bushnell CD,
    3. Jamison MG, et al

    . Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005;106:509–16 doi:10.1097/01.AOG.0000172428.78411.b0 pmid:16135580

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Carr ME

    . Diabetes mellitus: a hypercoagulable state. J Diabetes Complicat 2001;15:44–54 doi:10.1016/S1056-8727(00)00132-X pmid:11259926

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Martinelli I,
    2. Battaglioli T,
    3. Pedotti P, et al

    . Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003;102:1363–66 doi:10.1182/blood-2003-02-0443 pmid:12714502

    Abstract/FREE Full Text
29. 29.↵
    1. Coutinho JM,
    2. Zuurbier SM,
    3. Gaartman AE, et al

    . Association between anemia and cerebral venous thrombosis: case-control study. Stroke 2015;46:2735–40 doi:10.1161/STROKEAHA.115.009843

    Abstract/FREE Full Text
30. 30.↵
    1. Goeijenbier M,
    2. van Wissen M,
    3. van de Weg C, et al

    . Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol 2012;84:1680–96 doi:10.1002/jmv.23354 pmid:22930518

    CrossRefPubMed
31. 31.↵
    1. Li K,
    2. Wohlford-Lenane C,
    3. Perlman S, et al

    . Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis 2016;213:712–22 doi:10.1093/infdis/jiv499 pmid:26486634

    CrossRefPubMed
32. 32.↵
    1. Netravathi M,
    2. Jaychandran R,
    3. Bhat M, et al

    . Profile of 26 HIV seropositive individuals with cerebral venous thrombosis. J Neurol Sci 2017;378:69–74 doi:10.1016/j.jns.2017.04.034 pmid:28566183

    CrossRefPubMed
33. 33.↵
    Diagnosis and treatment program of novel coronavirus pneumonia (Trial Version 7). Released by National Health Commission & State Administration of Traditional Chinese Medicine on March 3, 2020. https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf. Accessed April 19, 2020
34. 34.↵
    1. Yang J,
    2. Zheng Y,
    3. Gou X, et al

    . Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91–95 doi:10.1016/j.ijid.2020.03.017 pmid:32173574

    CrossRefPubMed
35. 35.↵
    1. Ageno W,
    2. Becattini C,
    3. Brighton T, et al

    . Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008;117:93–102 doi:10.1161/CIRCULATIONAHA.107.709204 pmid:18086925

    Abstract/FREE Full Text
36. 36.↵
    1. Oxley TJ,
    2. Mocco J,
    3. Majidi S, et al

    . Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020;382:e60 doi:10.1056/NEJMc2009787 pmid:32343504

    CrossRefPubMed